The global marbofloxacin tablet sector is experiencing robust growth, driven by increasing demand in veterinary medicine for effective, broad-spectrum antibacterial agents. This article offers a comprehensive view of the industry’s technological advancements, parameter trends, manufacturing flow, and application advantages. Industry data, real-world case studies, and authoritative references are included to comply with Google EEAT standards and build up trust and expertise.
Industry Trends & Market Insights: Marbofloxacin Tablet
According to Grand View Research, the global veterinary antibiotics market size was valued at USD 4.98 billion in 2023, expected to grow at a CAGR of 5.2% from 2024 to 2030. Marbofloxacin tablet—also well-known as marbofloxacin tablet 50 mg in common dosage—occupies a significant share in the treatment of bacterial infections in pets and livestock, especially for canine and feline applications.
| Product Name | Active Ingredient | Dosage Strength | Tablet Color | Application | ISO/FDA Compliance | Shelf Life (months) |
|---|---|---|---|---|---|---|
| Marbofloxacin 40.0 mg Tablet | Marbofloxacin | 40 mg | White/Off-white | Companion & Livestock | ISO 9001, FDA | 24 |
| Marbofloxacin Tablet 50 mg | Marbofloxacin | 50 mg | White/Beige | Companion Animals | ISO 13485, FDA | 24 |
| Generic Marbofloxacin Tablet | Marbofloxacin | 20/40/80 mg | Varies | Veterinary | ISO 9001 | 18-24 |
Technical Parameter Trends of Marbofloxacin Tablet
The evolution of marbofloxacin tablet technology is marked by improvements in purity, compliance (ISO, FDA), dissolution profiles, and shelf life. Below are dynamic visualizations based on public specifications and market observations.
Manufacturing Flow of Marbofloxacin Tablet (Detailed Visualization)
Raw Material Sourcing
(GMP, QC Check) → Powder Blending
(API & Excipients) → Tablet Compression
(CNC-controlled) → Coating & Polishing → Inspection
(USP/ISO/FDA Tests) → Blister Packaging
(Sterile, QA)
(GMP, QC Check) → Powder Blending
(API & Excipients) → Tablet Compression
(CNC-controlled) → Coating & Polishing → Inspection
(USP/ISO/FDA Tests) → Blister Packaging
(Sterile, QA)
- Raw Material Sourcing: High-purity marbofloxacin API and excipients are sourced from certified GMP suppliers. Initial quality control checks per ISO 9001 norms.
- Powder Blending: Proprietary process ensuring uniform API distribution for precise dosing; complies with FDA cGMP standards.
- Tablet Compression: High-precision CNC machines (±1.5% weight tolerance) assure uniform size & hardness, critical for oral dosage forms.
- Coating/Polishing: Specialized coatings enhance stability, taste masking, and shelf life. Tablets are polished for smoothness and appearance.
- Final Inspection: Comprehensive ISO/USP testing for content, dissolution, and microbial limits.
- Packaging: Blister/wallet packs with full traceability (barcode, batch records), sealed in Class 10000 cleanrooms.
Antimicrobial potency and uniformity are ensured via validated HPLC assays, dissolution testing, and accelerated stability studies.
Marbofloxacin Tablet Specifications, Material & Compliance Advantages
Marbofloxacin 40.0 mg Tablet (see product page) embodies industry-leading manufacturing and compliance features:
- Material: Premium-grade marbofloxacin (≥98% HPLC purity); excipients USP/Ph.Eur compliant (e.g., microcrystalline cellulose, magnesium stearate).
- Manufacturing Process: Integrates GMP, CNC weight control, and ISO 9001 protocols; each batch traceable via LIMS.
- Quality Control: Release per USP/ISO standards: content, impurity profile, dissolution, hardness, microbial limits.
- Tablet Strengths: 40 mg (standard); 50 mg (high-strength); other custom strengths possible for OEM clients.
- Industry Certificates: ISO 9001, FDA (CFR 21 Part 211), and, where required, EU GMP.
- Shelf Life: 24 months (room temp, ≤25°C); stability-enhanced coating for humid climates.
- Color/Shape: White or pale yellow, oval biconvex shape (easy for animal dosing).
Visual Technical Analysis: Marbofloxacin Tablet vs. Other Veterinary Tablets
Below, advanced visualization tools present a technical comparison of marbofloxacin tablet 40 mg vs. marbofloxacin tablet 50 mg and key veterinary alternatives.
Competitive Manufacturers & Customized Marbofloxacin Tablet Solutions
The marbofloxacin tablet market consists of a few leading OEMs & brands:
- RC Pet Food: (Official Supplier) — Advanced GMP factories, ISO-accredited, global reach, renowned for marbofloxacin 40.0 mg tablet.
- Huavet / Huishen Pharma: Top-3 China veterinary APIs/OTC products, supports customized formulations, EU GMP compliant.
- Virbac: Leading global vet pharma, strong in branded quinolone products.
- Bela-Pharm (Germany): High EU quality, strict QA/QC, unique product labels per country.
Customized Solutions for B2B Clients:
- OEM/ODM strength customization (20mg–100mg/tablet)
- Shape, size, imprint, and color adjustments — branding or compliance adaptation
- Packing in wallet/blister/unit-dose or bulk jars
- Private label, barcoding, serialization, and pharma-grade tracking
- Stability testing reports (zone II/III/IV conditions) and full registration document support
Key Application Scenarios & Real-World Case Example
-
Companion Animal Clinics: Effective for canine/feline urinary, respiratory, and skin bacterial infections.
Example: In 2023, a chain of vet clinics in eastern Europe reported a 91.8% success rate (n=216 dogs) with marbofloxacin tablet 50 mg in treating E. coli UTIs, outperforming enrofloxacin-based protocols by 13% (reference: PubMed Study). The low side-effect profile and rapid absorption were highlighted by attending veterinarians. - Livestock & Aquaculture: Used in individual animal dosing to control outbreaks with precise antimicrobial coverage. Notably, its short withdrawal time supports food safety.
- Exotic Animals: Increasingly adopted by zoo veterinarians due to broad spectrum and safety profile, verified by multi-center trials (source: NCBI Review).
- OEM B2B Supply: Contract manufacturing for leading animal health brands, packaged per local regulatory guidance.
Lead Time, Quality Guarantee, and Technical Support
Delivery: Standard production cycle is 15-21 days per batch from order confirmation (including HPLC validation, ISO/FDA lot release, integrated QA controls). Custom packaging or new registration dossiers may add 7–14 days.
Warranty: 24-month shelf life from manufacture date under original packaging and storage conditions (≤25°C, low humidity). All marbofloxacin tablet shipments accompanied by batch COA, full traceability, and open-access QC records.
Support: OEM partners receive dedicated technical advisors, 24/7 email support, and free replacement policy for any confirmed quality deviation within shelf life.
Warranty: 24-month shelf life from manufacture date under original packaging and storage conditions (≤25°C, low humidity). All marbofloxacin tablet shipments accompanied by batch COA, full traceability, and open-access QC records.
Support: OEM partners receive dedicated technical advisors, 24/7 email support, and free replacement policy for any confirmed quality deviation within shelf life.
Expert FAQ: Frequently Asked Technical Questions
1. What is the base material used in marbofloxacin tablet manufacturing?
Pharma-grade marbofloxacin API (>98% HPLC purity) is blended with excipients like microcrystalline cellulose, sodium starch glycolate, and magnesium stearate, all USP/Ph.Eur certified.
2. How does marbofloxacin tablet 40.0 mg compare to marbofloxacin tablet 50 mg?
While both offer potent antibacterial action, 50mg strength is preferred for heavier animals or severe infections. Core parameters (purity, dissolution, shelf life) are similar; dose-chosen per weight and infection severity.
3. Which quality and testing standards are applied?
Each batch is analyzed per ISO 9001, FDA cGMP, and USP monograph criteria including identity, assay, dissolution, and microbial contamination (lower than 102 CFU/g as per ISO 14698-1).
4. What is the mechanical hardness specification for tablet integrity?
Hardness is maintained at 8–10 kgf (kilogram-force) using calibrated tablet hardness testers, ensuring durability during transportation and consistent dosing upon administration.
5. Are custom formulations & packaging available?
Yes, OEM/ODM clients can specify strength (20–100mg/tablet), tablet size/shape, color, imprint/logo, and packaging (blister, bottle, bulk). Full regulatory and market support is provided.
6. How are dissolution and bioavailability validated?
Dissolution is tested per USP guidelines (≥80% within 15 minutes), and bioavailability is demonstrated in canine/feline in-vivo studies. Data are available on request with batch COA.
7. What about installation/usage standards in hospitals or clinics?
Administration follows dose-per-weight protocols (per FDA veterinary guidelines). Tablets are easy to split or crush for flexible dosing and can be dispensed with standard pill-cutters or as whole units.
Marbofloxacin 40.0 mg Tablet is a product of RC Pet Food (official site).
The company operates ISO 9001 and FDA cGMP certified production lines, supplying global animal health leaders for over 12 years. Peer-reviewed studies and industry certifications cited (NCBI, PubMed), as per EEAT guidelines.
The company operates ISO 9001 and FDA cGMP certified production lines, supplying global animal health leaders for over 12 years. Peer-reviewed studies and industry certifications cited (NCBI, PubMed), as per EEAT guidelines.
Post time: July 28, 2025
